Search Results 291-300 of 16561 for Valproate

  1. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

    This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with other ...

  2. Umeclidinium and vilanterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Umeclidinium and vilanterol combination is used as maintenance treatment of air flow blockage in patients with chronic obstructive pulmonary disease (COPD).

  3. Electrophysiological Biomarkers for Parkinson's Disease - Mayo Clinic

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  4. Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery - Mayo Clinic

    This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients with metastatic kidney cancer who have ...

  5. Dolutegravir and rilpivirine (oral route) - Mayo Clinic

    This medicine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and it will also help your immune system. This may help ...

  6. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  7. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. Participation eligibility.

  8. Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure - Mayo Clinic

    About this study. Real-world evidence of the clinical course of patient symptoms following initiation of sacubitril/valsartan via PROs with a ...

  9. Alemtuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Alemtuzumab injection is used to treat the relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive ...

  10. Naproxen and esomeprazole (oral route) - Side effects & dosage - Mayo Clinic

    Naproxen and esomeprazole combination is used to relieve the symptoms of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis in adults and juvenile ...